Galectin Therapeutics Inc.

GALT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$11,525$13,771$7,431$15,120
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,204$1,656$1,854$2,132
Total Curr. Assets$12,729$15,427$9,285$17,252
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$136$175$243$243
Total NC Assets$136$175$243$243
Other Assets$0$0$0$0
Total Assets$12,865$15,602$9,528$17,495
Liabilities
Payables$5,390$5,865$6,534$5,656
Short-Term Debt$122,312$52$97,174$21,136
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,743$4,857$7,132$8,617
Total Curr. Liab.$136,445$10,774$110,840$35,409
LT Debt$0$120,458$10,813$85,109
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,723$1,537$136$47
Total NC Liab.$1,723$121,995$10,949$85,156
Other Liabilities$0$0$0$0
Cap. Leases$37$52$68$19
Total Liabilities$138,168$132,769$121,789$120,565
Equity
Pref Stock$490$2,213$2,223$2,223
Common Stock$64$63$63$62
Retained Earnings-$426,984-$418,761-$411,177-$401,572
AOCI$0$0$0$0
Other Equity$301,127$299,318$296,630$296,217
Total Equity-$125,303-$117,167-$112,261-$103,070
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$12,865$15,602$9,528$17,495
Net Debt$110,787$106,739$100,556$91,125